Safety Profile of HTX-019 Administered as an Intravenous Push in Cancer Patients: A Retrospective Review

Walton, GD

Walton, GD (reprint author), Clearview Canc Inst, Dept Pharm, Huntsville, AL 35805 USA.

ADVANCES IN THERAPY, 2019; 36 (3): 662

Abstract

Introduction: HTX-019 [CINVANTI((R)) (aprepitant injectable emulsion)] is a neurokinin 1 receptor antagonist (NK-1 RA) approved as a 30-min infusion f......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索